College of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Planta Med. 2012 Mar;78(4):390-2. doi: 10.1055/s-0031-1298175. Epub 2012 Jan 23.
Five selaginellin derivatives, including two new selaginellins termed selaginellins M (1) and N (2), and three previously identified compounds, selaginellin (3), selaginellin A (4), and selaginellin C (5), were isolated from the Selaginella tamariscina (Beauv.) Spring plant. In addition, four known biflavonoids, namely neocryptomerin ( 6), hinokiflavone (7), pulvinatabiflavone (8), and 7''- O-methylamentoflavone (9), were also isolated. The structures of new compounds 1 and 2 were elucidated by spectroscopic analysis. The cytotoxic activity of compounds 1- 9 was evaluated against a small panel of human cancer cell lines, including U251 (human glioma cells), HeLa (human cervical carcinoma cells), and MCF-7 (human breast cancer cells). The two new selaginellins, selaginellins M (1) and N (2), showed medium activity against the human cancer cell lines.
从卷柏(Beauv.)Spring 植物中分离得到了 5 种卷柏素衍生物,包括 2 种新型卷柏素,即卷柏素 M(1)和 N(2),以及 3 种先前鉴定的化合物,即卷柏素(3)、卷柏素 A(4)和卷柏素 C(5)。此外,还分离得到了 4 种已知的双黄酮类化合物,即新隐黄素(6)、扁柏黄素(7)、大波斯菊黄素(8)和 7''-O-甲基amentoflavone(9)。新化合物 1 和 2 的结构通过光谱分析阐明。对化合物 1-9 对一组小型人类癌细胞系(包括 U251(人神经胶质瘤细胞)、HeLa(人宫颈癌细胞)和 MCF-7(人乳腺癌细胞))的细胞毒性活性进行了评估。两种新型的卷柏素,即卷柏素 M(1)和 N(2),对人癌细胞系显示出中等活性。